HR and breast cancer: TET3 expression is decreased in BC tissue samples and MFC-7 BC cells compared with normal breast tissue samples and HBL-100 BC cells [28,44], while its expression is increased in TNBC, HR+, and HER+ subtypes and BC tissue samples compared with normal breast tissue samples [33,45].